Baidu
map

马晓伟赴上海调研指导新冠病毒疫苗接种工作

2021-04-03 国家卫生健康委 国家卫生健康委

国家卫生健康委党组书记、主任马晓伟4月1日在上海市调研指导新冠病毒疫苗接种工作。在上海期间,马晓伟与上海市负责同志深入沟通交流,到疫苗接种点实地考察疫苗接种情况,并召开座谈会,听取上海市政府和有关部门

国家卫生健康委党组书记、主任马晓伟4月1日在上海市调研指导新冠病毒疫苗接种工作。在上海期间,马晓伟与上海市负责同志深入沟通交流,到疫苗接种点实地考察疫苗接种情况,并召开座谈会,听取上海市政府和有关部门情况汇报。

马晓伟强调,上海市委市政府坚决贯彻习近平总书记重要指示精神,落实党中央、国务院决策部署,按照国务院联防联控机制全国电视电话会议要求,迅速行动,疫苗接种能力快速提升,日接种量明显提高,为如期完成接种任务打下坚实基础。要立足国际大都市定位,不断总结探索大型城市大规模接种经验,加快推进疫苗接种工作,最大程度提高疫苗接种率。要坚守安全底线,保障接种现场组织秩序,严格规范进行接种,做好疑似异常反应监测和应急救治。要加强正面宣传引导,防止简单化、一刀切。同时,慎终如始落实“外防输入、内防反弹”防控措施,做好“清明”“五一”假期防控工作,确保不出现规模性疫情输入和反弹。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2083351, encodeId=0c77208335160, content=<a href='/topic/show?id=b7cce09742a' target=_blank style='color:#2F92EE;'>#病毒疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70974, encryptionId=b7cce09742a, topicName=病毒疫苗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1dbc2500219, createdName=huagfeg, createdTime=Tue Dec 28 22:19:46 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1257973, encodeId=0c15125e97371, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70501, encryptionId=f538e0501e9, topicName=疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Sun Apr 04 15:19:46 CST 2021, time=2021-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1492759, encodeId=92101492e5913, content=<a href='/topic/show?id=ed6f101463f9' target=_blank style='color:#2F92EE;'>#马晓伟#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101463, encryptionId=ed6f101463f9, topicName=马晓伟)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8108959921, createdName=lilianxiang, createdTime=Sun Apr 04 15:19:46 CST 2021, time=2021-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953601, encodeId=51c5953601aa, content=调研结果, beContent=null, objectType=article, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210403/5ff406be14214a2382446bee2a6a5a17/d86ca8b32a014802a07fb644f93b3a73.jpg, createdBy=90132272125, createdName=废不废柴, createdTime=Sat Apr 03 18:25:00 CST 2021, time=2021-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1751500, encodeId=5b1e1e51500aa, content=<a href='/topic/show?id=3ba692039f7' target=_blank style='color:#2F92EE;'>#调研#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92039, encryptionId=3ba692039f7, topicName=调研)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=958d36313994, createdName=天堂的云, createdTime=Tue Jun 01 09:19:46 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1029330, encodeId=02721029330e8, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Sat Apr 03 03:19:46 CST 2021, time=2021-04-03, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2083351, encodeId=0c77208335160, content=<a href='/topic/show?id=b7cce09742a' target=_blank style='color:#2F92EE;'>#病毒疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70974, encryptionId=b7cce09742a, topicName=病毒疫苗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1dbc2500219, createdName=huagfeg, createdTime=Tue Dec 28 22:19:46 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1257973, encodeId=0c15125e97371, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70501, encryptionId=f538e0501e9, topicName=疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Sun Apr 04 15:19:46 CST 2021, time=2021-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1492759, encodeId=92101492e5913, content=<a href='/topic/show?id=ed6f101463f9' target=_blank style='color:#2F92EE;'>#马晓伟#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101463, encryptionId=ed6f101463f9, topicName=马晓伟)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8108959921, createdName=lilianxiang, createdTime=Sun Apr 04 15:19:46 CST 2021, time=2021-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953601, encodeId=51c5953601aa, content=调研结果, beContent=null, objectType=article, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210403/5ff406be14214a2382446bee2a6a5a17/d86ca8b32a014802a07fb644f93b3a73.jpg, createdBy=90132272125, createdName=废不废柴, createdTime=Sat Apr 03 18:25:00 CST 2021, time=2021-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1751500, encodeId=5b1e1e51500aa, content=<a href='/topic/show?id=3ba692039f7' target=_blank style='color:#2F92EE;'>#调研#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92039, encryptionId=3ba692039f7, topicName=调研)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=958d36313994, createdName=天堂的云, createdTime=Tue Jun 01 09:19:46 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1029330, encodeId=02721029330e8, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Sat Apr 03 03:19:46 CST 2021, time=2021-04-03, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2083351, encodeId=0c77208335160, content=<a href='/topic/show?id=b7cce09742a' target=_blank style='color:#2F92EE;'>#病毒疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70974, encryptionId=b7cce09742a, topicName=病毒疫苗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1dbc2500219, createdName=huagfeg, createdTime=Tue Dec 28 22:19:46 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1257973, encodeId=0c15125e97371, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70501, encryptionId=f538e0501e9, topicName=疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Sun Apr 04 15:19:46 CST 2021, time=2021-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1492759, encodeId=92101492e5913, content=<a href='/topic/show?id=ed6f101463f9' target=_blank style='color:#2F92EE;'>#马晓伟#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101463, encryptionId=ed6f101463f9, topicName=马晓伟)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8108959921, createdName=lilianxiang, createdTime=Sun Apr 04 15:19:46 CST 2021, time=2021-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953601, encodeId=51c5953601aa, content=调研结果, beContent=null, objectType=article, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210403/5ff406be14214a2382446bee2a6a5a17/d86ca8b32a014802a07fb644f93b3a73.jpg, createdBy=90132272125, createdName=废不废柴, createdTime=Sat Apr 03 18:25:00 CST 2021, time=2021-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1751500, encodeId=5b1e1e51500aa, content=<a href='/topic/show?id=3ba692039f7' target=_blank style='color:#2F92EE;'>#调研#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92039, encryptionId=3ba692039f7, topicName=调研)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=958d36313994, createdName=天堂的云, createdTime=Tue Jun 01 09:19:46 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1029330, encodeId=02721029330e8, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Sat Apr 03 03:19:46 CST 2021, time=2021-04-03, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2083351, encodeId=0c77208335160, content=<a href='/topic/show?id=b7cce09742a' target=_blank style='color:#2F92EE;'>#病毒疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70974, encryptionId=b7cce09742a, topicName=病毒疫苗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1dbc2500219, createdName=huagfeg, createdTime=Tue Dec 28 22:19:46 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1257973, encodeId=0c15125e97371, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70501, encryptionId=f538e0501e9, topicName=疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Sun Apr 04 15:19:46 CST 2021, time=2021-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1492759, encodeId=92101492e5913, content=<a href='/topic/show?id=ed6f101463f9' target=_blank style='color:#2F92EE;'>#马晓伟#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101463, encryptionId=ed6f101463f9, topicName=马晓伟)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8108959921, createdName=lilianxiang, createdTime=Sun Apr 04 15:19:46 CST 2021, time=2021-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953601, encodeId=51c5953601aa, content=调研结果, beContent=null, objectType=article, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210403/5ff406be14214a2382446bee2a6a5a17/d86ca8b32a014802a07fb644f93b3a73.jpg, createdBy=90132272125, createdName=废不废柴, createdTime=Sat Apr 03 18:25:00 CST 2021, time=2021-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1751500, encodeId=5b1e1e51500aa, content=<a href='/topic/show?id=3ba692039f7' target=_blank style='color:#2F92EE;'>#调研#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92039, encryptionId=3ba692039f7, topicName=调研)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=958d36313994, createdName=天堂的云, createdTime=Tue Jun 01 09:19:46 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1029330, encodeId=02721029330e8, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Sat Apr 03 03:19:46 CST 2021, time=2021-04-03, status=1, ipAttribution=)]
    2021-04-03 废不废柴

    调研结果

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2083351, encodeId=0c77208335160, content=<a href='/topic/show?id=b7cce09742a' target=_blank style='color:#2F92EE;'>#病毒疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70974, encryptionId=b7cce09742a, topicName=病毒疫苗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1dbc2500219, createdName=huagfeg, createdTime=Tue Dec 28 22:19:46 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1257973, encodeId=0c15125e97371, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70501, encryptionId=f538e0501e9, topicName=疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Sun Apr 04 15:19:46 CST 2021, time=2021-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1492759, encodeId=92101492e5913, content=<a href='/topic/show?id=ed6f101463f9' target=_blank style='color:#2F92EE;'>#马晓伟#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101463, encryptionId=ed6f101463f9, topicName=马晓伟)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8108959921, createdName=lilianxiang, createdTime=Sun Apr 04 15:19:46 CST 2021, time=2021-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953601, encodeId=51c5953601aa, content=调研结果, beContent=null, objectType=article, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210403/5ff406be14214a2382446bee2a6a5a17/d86ca8b32a014802a07fb644f93b3a73.jpg, createdBy=90132272125, createdName=废不废柴, createdTime=Sat Apr 03 18:25:00 CST 2021, time=2021-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1751500, encodeId=5b1e1e51500aa, content=<a href='/topic/show?id=3ba692039f7' target=_blank style='color:#2F92EE;'>#调研#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92039, encryptionId=3ba692039f7, topicName=调研)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=958d36313994, createdName=天堂的云, createdTime=Tue Jun 01 09:19:46 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1029330, encodeId=02721029330e8, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Sat Apr 03 03:19:46 CST 2021, time=2021-04-03, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=2083351, encodeId=0c77208335160, content=<a href='/topic/show?id=b7cce09742a' target=_blank style='color:#2F92EE;'>#病毒疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70974, encryptionId=b7cce09742a, topicName=病毒疫苗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1dbc2500219, createdName=huagfeg, createdTime=Tue Dec 28 22:19:46 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1257973, encodeId=0c15125e97371, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70501, encryptionId=f538e0501e9, topicName=疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Sun Apr 04 15:19:46 CST 2021, time=2021-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1492759, encodeId=92101492e5913, content=<a href='/topic/show?id=ed6f101463f9' target=_blank style='color:#2F92EE;'>#马晓伟#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101463, encryptionId=ed6f101463f9, topicName=马晓伟)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8108959921, createdName=lilianxiang, createdTime=Sun Apr 04 15:19:46 CST 2021, time=2021-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953601, encodeId=51c5953601aa, content=调研结果, beContent=null, objectType=article, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210403/5ff406be14214a2382446bee2a6a5a17/d86ca8b32a014802a07fb644f93b3a73.jpg, createdBy=90132272125, createdName=废不废柴, createdTime=Sat Apr 03 18:25:00 CST 2021, time=2021-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1751500, encodeId=5b1e1e51500aa, content=<a href='/topic/show?id=3ba692039f7' target=_blank style='color:#2F92EE;'>#调研#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92039, encryptionId=3ba692039f7, topicName=调研)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=958d36313994, createdName=天堂的云, createdTime=Tue Jun 01 09:19:46 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1029330, encodeId=02721029330e8, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Sat Apr 03 03:19:46 CST 2021, time=2021-04-03, status=1, ipAttribution=)]
    2021-04-03 公卫新人

    新冠肺炎,疫情何时才能消失

    0

相关资讯

中疾控回应“西安确诊病例接种疫苗后仍感染”事件,存三种可能

疫苗的保护率“不是100%”,“相对安全而不是”绝对安全”

Lancet:哺乳期妇女要不要接种新冠疫苗

为了改善母婴健康并保持公众对疫苗的信心,疫苗制造商和监管机构必须与哺乳科学家、传染病专家和公共卫生专家密切合作,在产品开发的早期阶段评估母乳喂养妇女的疫苗安全性。

柳叶刀:新冠肺炎候选疫苗Sputnik V似乎安全有效

Denis Logunov及其同事在“柳叶刀”杂志上报告了他们的Sputnik V新冠肺炎疫苗3期试验的中期结果。

Cell :新冠病毒变异,疫苗效力明显下降!

随着全球新冠大流行,病毒突变频现,包括具有更强的传播能力或逃避免疫系统的变种。到目前为止,英国、南非、巴西、美国等国接连报告发现变异新冠病毒。

NEJM:加州医护人员接种SARS-CoV-2疫苗后感染情况调查

疫苗的效力在试验环境之外保持不变。这些数据强调了持续的公共卫生缓解措施(佩戴口罩、保持社交距离、每日症状筛查和定期检测)的重要性,即使在疫苗接种率较高的地区也是如此,直到达到普遍的群体免疫力为止。

bioRxiv:应对全球新冠病毒变种,防御南非变种已成为重中之重!

现有疫苗诱导的抗体仍可以中和巴西冠状病毒P.1变体,但水平较低。

Baidu
map
Baidu
map
Baidu
map